A detailed history of Exchange Traded Concepts, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 69,503 shares of VKTX stock, worth $2.94 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
69,503
Previous 16,535 320.34%
Holding current value
$2.94 Million
Previous $876,000 402.28%
% of portfolio
0.11%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$49.84 - $70.47 $2.64 Million - $3.73 Million
52,968 Added 320.34%
69,503 $4.4 Million
Q2 2024

Aug 13, 2024

BUY
$47.39 - $80.2 $783,593 - $1.33 Million
16,535 New
16,535 $876,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.